Effective oncolytic vaccinia therapy for human sarcomas.
about
Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing miceIsolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.Oncolytic Poxviruses.Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain.Strategies and developments of immunotherapies in osteosarcomaFeatures of the Antitumor Effect of Vaccinia Virus Lister StrainVaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancerEffect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaInflammatory stress and sarcomagenesis: a vicious interplay.Oncolytic vaccinia virotherapy for endometrial cancerDouble-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumorsGrowth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis.
P2860
Q33927165-EFB4BD5B-29BA-4EEB-BE58-C3C38CC93196Q34662879-139380FB-6E66-485A-92E5-96BA0E48D325Q35234349-B0A1A71A-EE66-42C2-A7BA-972DCC49EC8DQ36140704-CF147D89-E004-4D4F-BECB-458D713C374AQ36503128-A2B23999-7F75-4721-B3BF-4D72041AFF5BQ36507293-095F6EB2-87AB-4902-B7E6-08BF90869C76Q36903415-C2A352E0-502A-4DC6-8981-AF09E7471D0CQ37346179-AE28222E-6037-4457-88FE-624C6869E766Q37378867-2E6AA2F6-841A-4BD4-A8E9-90D0DDF3DBF8Q37688850-0F625565-711F-4968-B435-D013ADA65D2EQ39132287-C1D7D87C-1C72-48E6-88EC-BCDA9E6A53E1Q39175316-C19E4DF2-ACF0-41C4-B314-B1C0F7F1C99EQ39213379-F43A6F61-617A-4075-886C-E4F8465D6AB8Q39247147-6CD5694B-5C90-432C-9392-7B10E271D9CC
P2860
Effective oncolytic vaccinia therapy for human sarcomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effective oncolytic vaccinia therapy for human sarcomas.
@ast
Effective oncolytic vaccinia therapy for human sarcomas.
@en
type
label
Effective oncolytic vaccinia therapy for human sarcomas.
@ast
Effective oncolytic vaccinia therapy for human sarcomas.
@en
prefLabel
Effective oncolytic vaccinia therapy for human sarcomas.
@ast
Effective oncolytic vaccinia therapy for human sarcomas.
@en
P2093
P2860
P1476
Effective oncolytic vaccinia therapy for human sarcomas.
@en
P2093
Chun-Hao Chen
Nanhai Chen
Natalya Chernichenko
Pingdong Li
Richard J Wong
Richard L Bakst
Shuangba He
Zhenkun Yu
P2860
P304
P356
10.1016/J.JSS.2011.11.1030
P577
2011-12-14T00:00:00Z